BioGaia AB (publ)
BIOG-B
Rang in aandelen
#7837
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in... BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
Aandeelprijs
$13.86
Laatst gesynchroniseerd: 2026-10-16
Marktkapitalisatie
$1.37B
Verandering (1 dag)
0.65%
Verandering (1 jaar)
23.21%
Land
SE
Handel BioGaia AB (publ) (BIOG-B)
Categorie
Healthcare
Marktkapitalisatie van BioGaia AB (publ)(BIOG-B)
Marktkapitalisatie: $1.37B
Vanaf October 2026 heeft BioGaia AB (publ) een marktkapitalisatie van $1.37B. Dit maakt BioGaia AB (publ) volgens onze gegevens het 7837th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van BioGaia AB (publ) van 2015 tot 2026
BIOG-B vergeleken met de top 5 populairste stocks
